Published December 2005 | Version v1
Journal article

Clinical value of combined measurement of serum alpha-fetoprotein, alpha-L-fucosidase and ferritin levels in the diagnosis of primary liver cancer

  • 1. Department of Clinical Laboratory, Affiliated Hospital, Medical College of Chinese People's Armed Police Forces (China)

Description

Objective: To investigate the clinical value of combined measurement of serum alpha-fetoprotein (AFP), alpha-L-fucosidase (AFU) and ferritin (SF) levels in the diagnosis of primary liver cancer. Methods: Serum AFP, AFU (with RIA) and SF (with biochemical method) were determined in 52 patients with primary liver cancer and 40 controls. Results: The positive rates of AFP, AFU and SF in patient with liver cancer were 82.7%, 86.6% and 76.9%, respectively. Positive rates with combined measurement of AFP plus AFU, AFP plus SF, and AFP plus AFU, SF were 94.2%, 90.4% and 98.1% respectively. Conclusion: Combined measurement of AFP, AFU and SF can significantly increase the positive rate in the diagnosis of primary liver cancer. (authors)

Additional details

Publishing Information

Journal Title
Journal of Radioimmunology
Journal Volume
18
Journal Issue
6
Journal Page Range
p. 432-434
ISSN
1008-9810

Optional Information

Notes
2 tabs., 5 refs.